Table 3 Clinicians’ self-reported awareness of NF clinical guideline publications
Total number of respondents (N) | Aware of guideline document N (%) | Unaware of guideline document N (%) | Unsure N (%) | |
|---|---|---|---|---|
Neurofibromatosis 1 Guidelines | ||||
Stewart et al. (2018) | 62 | 43 (69.4%) | 16 (25.8%) | 3 (4.8%) |
Ferner et al. (2007) | 63 | 50 (79.4%) | 11 (17.5%) | 2 (3.2%) |
Evans et al. (2017a) | 63 | 47 (58.7%) | 21 (33.3%) | 5 (7.9%) |
Miller et al. (2019) | 62 | 43 (69.4%) | 17 (27.4%) | 2 (3.2%) |
Neurofibromatosis 2 Guidelinesa | ||||
Evans et al. (2005) | 61 | 33 (54.1%) | 26 (42.6%) | 2 (3.3%) |
Evans et al. (2017b) | 61 | 40 (65.6%) | 18 (29.5%) | 3 (4.9%) |
Schwannomatosis Guidelinesa | ||||
Evans et al. (2017b) | 62 | 33 (53.2%) | 22 (35.5%) | 7 (11.3%) |